Brain cancer claims 1,600 lives in Australia each year. Our research brings hope and better outcomes.
We drive practice-changing trials and global collaborations to improve care and survival in neuro-oncology.
Our community of healthcare professionals, researchers and consumers unites to expand treatment options.
18th COGNO Annual Scientific Meeting
Integrated Precision Care for Brain Cancer
We are delighted to announce that the 18th COGNO Annual Scientific Meeting will take place from 26-27 August 2026 at the Adelaide Convention Centre, South Australia. Leading international and national experts will join us for a dynamic program exploring cutting-edge advances and future directions in neuro-oncology – spanning clinical trials, translational research and supportive care.
Welcome to COGNO
Welcome to Cogno
Cooperative Trials Group for Neuro-Oncology
COGNO is a not-for-profit network of healthcare professionals, researchers and consumer representatives dedicated to improving survival and quality of life for people affected by brain and spinal tumours. We collaborate nationally and internationally to develop and support the conduct of clinical trials and research to identify the most effective treatments and achieve better health outcomes.
WHAT WE DO
COGNO is 1 of 14 collaborative Cancer Clinical Trials Groups established by the Australian Government under the Support for Cancer Clinical Trials Program. We develop investigator-initiated clinical trial protocols for patients diagnosed with brain and spinal tumours across Australia and New Zealand. We also provide education and updates about relevant practice-changing brain tumour trials and trials research.
WHY IT’S IMPORTANT
Around 2000 Australians develop brain cancer each year. While outcomes for other cancers have steadily improved over time, this has not been the case for brain cancer. The five-year survival rate for all types of primary brain cancer has remained low, at around 22%, over the past 30 years. The five-year survival rate for glioblastoma, the most common primary brain cancer in adults, remains poor at just 5%. More effort is required to discover new treatments and interventions for brain cancer. Clinical trials are vital for translating research into clinical practice to improve survival and quality of life.
Ways to
get involved
Find out more
View available
awards
Find out more
August 26th
Fundraiser
ride for
Brain Cancer
Find out more
Ways to
get involved
Find out more
View available
awards
Find out more
August 26th
Fundraiser
ride for
Brain Cancer
Ways to get involved
Clinicians & Researchers
Join a multidisciplinary network of healthcare professionals, researchers and consumer advocates committed to improving outcomes for people with brain cancers through clinical trials. Collaborate with leaders on cutting-edge Australian-led and international trials.Find out more
Patients & Families
Support COGNO’s mission through donations or by hosting fundraising events. We are licensed to fundraise across Australia and have Deductible Gift Recipient (DGR) status. We are registered with the Australian Charities and Not-for-profits Commission. Please contact us here for further information.Find out more
Clinicians & Researchers
Join a multidisciplinary network of healthcare professionals and researchers who are committed to improving the outcomes of people with brain cancers through clinical trials. You will have the opportunity to work with Australian leaders in brain cancer research and contribute to much needed cutting-edge clinical trials. COGNO is involved in Australian-led trials as well as with our international collaborators in Europe and North America.
Join a multidisciplinary network of healthcare professionals and researchers who are committed to improving the outcomes of people with brain cancers through clinical trials. You will have the opportunity to work with Australian leaders in brain cancer research and contribute to much needed cutting-edge clinical trials. COGNO is involved in Australian-led trials as well as with our international collaborators in Europe and North America.
Patients & Families
We have ACNC and Deductible gift recipient (DGR) status and are licensed to fundraise across Australia. You can make a personal donation via the link below or consider holding an event in your area to support COGNO. Please contact info@cogno.org for further information.
We have ACNC and Deductible gift recipient (DGR) status and are licensed to fundraise across Australia. You can make a personal donation via the link below or consider holding an event in your area to support COGNO. Please contact info@cogno.org for further information.
Member Benefits
COGNO has more than 1150 multi-disciplinary members including healthcare professionals, researchers, trial coordinators and consumer advocates. Members enjoy the following benefits:
-
- Free membership
- Reduced Annual Scientific Meeting registration fees
- Networking opportunities with clinicians and researchers in Australia, New Zealand and internationally
- Participation in new clinical trials for brain cancer as a member site
- Support for trial concept development through workshops and the Scientific Advisory Committee
- Updates on current clinical trials and funding opportunities
- Updates on available Awards, including COGNO’s prestigious Hubert Stuerzl Memorial Educational Award, Jenny Chow Award and ASM Abstract Awards (for Young Investigator, Best Oral and Best Poster presentations)
- Access to recordings of COGNO Education Events.
- Discounted Clinical Oncology Society of Australia (COSA) membership
Member benefits
COGNO has more than 1150 multi-disciplinary members including healthcare professionals, researchers, trial coordinators and consumer advocates. Members enjoy the following benefits:
- Free membership
- Reduced Annual Scientific Meeting registration fees
- Networking opportunities with clinicians and researchers in Australia, New Zealand and internationally
- Participation in new clinical trials for brain cancer as a member site
- Support for trial concept development through workshops and the Scientific Advisory Committee
- Updates on current clinical trials and funding opportunities
- Updates on available Awards, including COGNO’s prestigious Hubert Stuerzl Memorial Educational Award and ASM Abstract Awards (for Young Investigator, Best Oral and Best Poster presentations)
- Access to recordings of COGNO Education Events.
- Discounted Clinical Oncology Society of Australia (COSA) membership
Member Benefits
COGNO has more than 1150 multi-disciplinary members including healthcare professionals, researchers, trial coordinators and consumer advocates. Members enjoy the following benefits:
- Free membership
- Reduced Annual Scientific Meeting registration fees
- Networking opportunities with clinicians and researchers in Australia, New Zealand and internationally
- Participation in new clinical trials for brain cancer as a member site
- Support for trial concept development through workshops and the Scientific Advisory Committee
- Updates on current clinical trials and funding opportunities
- Updates on available Awards, including COGNO’s prestigious Hubert Stuerzl Memorial Educational Award and ASM Abstract Awards (for Young Investigator, Best Oral and Best Poster presentations)
- Access to recordings of COGNO Education Events.
- Discounted Clinical Oncology Society of Australia (COSA) membership
News & Articles
Browse all
Browse all
Browse all
Your donations to COGNO’s brain cancer research make a difference
The Australian Government provides base level funding to COGNO via the Support for Cancer Clinical Trials Program. We are mainly supported through the voluntary efforts of our member clinical investigators, researchers and consumer advocates. To achieve our objectives and improve our impact additional support is required.
Your donations will help fund new brain cancer trials and research, expand trial sites and improve equity of access for participants. Together, we can create long-term impact.
